Optimal Target of Activated Clotting Time During PCI and Outcomes: The OPTIMAL-ACT Trial
- 1 August 2025
- journal article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 18 (8) , e015291
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesCirculation, 2022
- Relation of Activated Clotting Times During Percutaneous Coronary Intervention to OutcomesThe American Journal of Cardiology, 2016
- Relationship between heparin anticoagulation and clinical outcomes in coronary stent interventionJACC, 2003
- Heparin dosing in patients undergoing coronary interventionThe American Journal of Cardiology, 1998
- Nonoperative Dilatation of Coronary-Artery StenosisNew England Journal of Medicine, 1979